0

Global Bronchitis Drugs Market 2018-2022

  • Published: Dec 2018
  • Pages: 111
  • SKU: IRTNTR23805
Technavio

The 2022-2026 version of this report is just being published. Buy it now and get up to $1000 worth of free customization!

Get me the latest version! (includes COVID-19 impact)
Safe and Secure SSL Encrypted
  • 2500.00
  • USD

The bronchitis drugs market size will grow by USD 2.87 billion during 2018-2022. This report offers an analysis of the market based on application (acute bronchitis and chronic bronchitis) and drug type (antibiotics, anti-inflammatory drugs, bronchodilators, and mucolytics). This bronchitis drugs market research report further presents in-depth insights into the growth prospects of the market across geographic regions such as the Americas, EMEA, and APAC. The report analyzes the market’s competitive landscape and offers information on several bronchitis drug manufacturers including AstraZeneca, GlaxoSmithKline, Novartis, and Sanofi.

Below are some of the key findings from the bronchitis drug industry analysis report

Global Bronchitis Drugs Market

See the complete table of contents and list of exhibits, as well as selected illustrations and example pages from this report.

Get a FREE Sample now!

Global bronchitis drug industry overview

The increasing incidences of bronchitis is one of the critical reasons expected to propel the bronchitis drug market growth in the next five years. The rising prevalence of acute and chronic bronchitis over the past few years will boost the demand for bronchitis drugs during the forecast period. Chronic bronchitis, which is a type of COPD, has a high prevalence across the globe. COPD is considered as the 3rd-leading cause of death worldwide, and the incidence of COPD ranges between 15% and 20% in Europe, for people aged 40 years and above. Risk factors for COPD include smoking cigarettes and air pollutants. It is estimated that around 20% of smokers develop COPD. These factors coupled with the growing prevalence of bronchitis are forecasted to fuel the growth of the global bronchitis drugs market over the next five years. The strong pipeline due to the extensive R&D in the field of bronchitis therapeutics will drive the bronchitis drugs market to grow at a CAGR of close to 4% during the forecast period.

Top bronchitis drug manufacturers covered in this market research report

The bronchitis drugs market is moderately fragmented with the presence of several bronchitis drug manufacturers who offer drugs for application in the treatment of acute bronchitis and chronic bronchitis. Many established bronchitis drug manufacturers are vying for their share of the market, and the new players must differentiate themselves to gain vital traction over their peers. By offering a complete analysis of the market’s competitive landscape and with information on the products offered by the companies, this bronchitis drug industry analysis report will allow the clients to identify new growth opportunities and design innovative strategies for improving their share in the market.

The report offers a complete analysis of various bronchitis drug manufacturers including:

  • AstraZeneca
  • GlaxoSmithKline
  • Novartis
  • Sanofi

Bronchitis drugs market segmentation based on geographic regions

  • The Americas
  • EMEA
  • APAC

EMEA will account for the highest growth in this market throughout the forecast period. The high prevalence of bronchitis in European countries is one of the primary reasons behind the rapid growth of anesthesia laryngeal market in this region.

Bronchitis drugs market segmentation based on application type

  • Acute bronchitis
  • Chronic bronchitis

The acute bronchitis application type will account for the largest share in the bronchitis drugs market. The report provides an accurate prediction of the contribution of various segments to the growth of the bronchitis drugs market size.

Key highlights of the global bronchitis drugs market for the forecast years 2018-2022:

  • CAGR of the market during the forecast period 2018-2022
  • Detailed information on factors that will accelerate the growth of the bronchitis drugs market during the next five years
  • Precise estimation of the global bronchitis drugs market size and its contribution to the parent market
  • Accurate predictions on upcoming trends and changes in consumer behavior
  • The growth of the bronchitis drugs industry across various geographies such as the Americas, APAC, and EMEA
  • A thorough analysis of the market’s competitive landscape and detailed information on several vendors
  • Comprehensive details on factors that will challenge the growth of bronchitis drug manufacturers

We can help! Our analysts can customize this market research report to meet your requirements. Get in touch

 

Read More Read Less

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: RESEARCH METHODOLOGY

PART 04: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

PART 05: PIPELINE ANALYSIS

  • Bronchitis pipeline

PART 06: MARKET SIZING

  • Market definition
  • Market sizing 2017
  • Market size and forecast 2017-2022

PART 07: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 08: SEGMENTATION BY DRUG TYPE

  • Antibiotics
  • Anti-inflammatory drugs
  • Bronchodilators
  • Mucolytics

PART 09: MARKET SEGMENTATION BY APPLICATION

  • Segmentation by application
  • Comparison by application
  • Acute bronchitis – Market size and forecast 2017-2022
  • Chronic bronchitis – Market size and forecast 2017-2022
  • Market opportunity by application

PART 10: CUSTOMER LANDSCAPE

PART 11: REGIONAL LANDSCAPE

  • Geographical segmentation
  • Regional comparison
  • EMEA – Market size and forecast 2017-2022
  • Americas – Market size and forecast 2017-2022
  • APAC – Market size and forecast 2017-2022
  • Market opportunity

PART 12: DECISION FRAMEWORK

PART 13: DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges

PART 14: MARKET TRENDS

  • High use of antibiotics for bronchitis treatment
  • Use of off-label drugs for bronchitis

PART 15: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption

PART 16: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • AstraZeneca
  • GlaxoSmithKline
  • Novartis
  • Sanofi

PART 17: APPENDIX

  • List of abbreviations

 

 

Research Framework

Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

TechnavioINFORMATION SOURCES

Primary sources

  • Manufacturers and suppliers
  • Channel partners
  • Industry experts
  • Strategic decision makers

Secondary sources

  • Industry journals and periodicals
  • Government data
  • Financial reports of key industry players
  • Historical data
  • Press releases
Technavio

TechnavioDATA ANALYSIS

Data Synthesis

  • Collation of data
  • Estimation of key figures
  • Analysis of derived insights

Data Validation

  • Triangulation with data models
  • Reference against proprietary databases
  • Corroboration with industry experts
Technavio

TechnavioREPORT WRITING

Qualitative

  • Market drivers
  • Market challenges
  • Market trends
  • Five forces analysis

Quantitative

  • Market size and forecast
  • Market segmentation
  • Geographical insights
  • Competitive landscape
Interested in this report?
Get your FREE sample now!
Safe and Secure SSL Encrypted
Technavio

Single User:

2500 USD

Technavio Get the report (PDF) sent to your email within minutes.

Subscribe & Save

Get lifetime access to our
Technavio Insights

Want to customize this report?

This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time.

We offer $1000 worth of FREE customization at the time of purchase
Technavio
Enquire Before Buying
  1. Home
  2. Health Care
  3. Published Report
17,000 reports available | Plans starting from just 5,000 USD | Get FREE trial>>